Patient discovers decade-long chemotherapy was for misdiagnosed brain inflammation
Becky Jones, now 33, learned after 11 years of chemotherapy that she never had brain cancer but a treatable brain inflammation, joining dozens of patients suing University Hospitals Coventry and Warwickshire NHS Trust.
Becky Jones was told at age 21 that she had an aggressive grade-four glioblastoma and was prescribed lifelong temozolomide chemotherapy by consultant Ian Brown at University Hospitals Coventry and Warwickshire. The treatment caused chronic nausea, fatigue and other severe side effects, limiting her career and personal life. After a 2024 phone call about stopping the drugs, independent specialists in 2025 determined she actually suffered from tumefactive demyelination, an inflammatory brain condition normally managed with steroids.
Her lawyer Fiona Tinsley says she joins over 40 patients suing the trust for prolonged, unnecessary cancer therapy, a practice the Royal College of Physicians’ preliminary review described as lacking clinical justification and betraying patient trust. The trust declined comment on individual cases but announced new oversight measures for temozolomide prescribing. Jones hopes the legal action will prevent similar misdiagnoses.
Why it matters
The case highlights dangerous diagnostic errors and the need for stricter oversight of long-term chemotherapy.
In this story
